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The occurrence of thrombocytopenia in Plasmodium
vivax malaria is well-documented. In spite of being a com-
mon observation, its prognostic implications in context
with parasite density has not been evaluated. In view of
the paucity of data, we attempted to study the correlation
of platelet count with parasite density in P. vivax
monoinfection.
This prospective study was carried out on patients
attending outpatient clinic from June 2011 to December
2011. The study was conducted on  patients coming to out
patient department at the time of first consultation for fe-
ver in which diagnosis of P. vivax monoinfection was made
by peripheral blood smear (PBS) and rapid diagnostic test
(RDT). Patients having severe malarial manifestations
were enrolled in another observational study (under pro-
cess) and confirmation of malarial species in them was
made by PCR analysis. Due to inclusion of large number
of patients in the present study, we used an ‘OptiMAL®
Rapid Malaria Dipstick Test’ to rule out concomitant low
density P. falciparum mixed infection. This test detects
the presence of Plasmodium lactate dehydrogenase
(pLDH); an enzyme produced both by the sexual and
asexual forms of the parasite. The presence of pLDH is
revealed using monoclonal antibodies directed against
isoforms of the enzyme. This test detects parasitemia lev-
els of 100–200 parasites per μl of blood (corresponding
to a parasitemia of 0.002–0.004%). Another point against
the presence of associated P. falciparum infection is that
such a low parasitemia of P. falciparum so as to be unde-
tectable both by the dipstick test and standard microscopy,
is highly unlikely to cause such profound thrombocytope-
nia.
The possibilities of other concurrent similar illness
causing thrombocytopenia were ruled out by appropriate
and stringent laboratory investigations. Details are given
in our previous study1. Platelet count was done by fully
automated counter and the results were derived from di-
rectly measured platelet pulses, multiplied by a calibra-
tion constant and expressed in 1000 thrombocytes/l of
whole blood. A written informed consent was mandatory
and those who refused to give the written consent or had
other concurrent illness were not included in the study.
This study  includes 599 patients of P. vivax
monoinfection, but parasite density was done only in 546
patients fulfilling the eligibility criteria. The age distribu-
tion range included in the study was 1–60 yr and sex ratio
was 2.33 (male : female = 382 : 164). The mean ± SD
platelet count and mean ± SD parasite density were
90199.6 ± 57414.9 and 6733.4 ± 9523.8, respectively.
Thrombocytopenia (<150,000/mm3) was present in
85.71% (468/546) patients with a mean platelet count of
72715.8 ± 38625.4. Statistical analysis done by correla-
tion coefficient did not show any association between plate-
let count and parasite load [correlation coefficient (R2) =
0.000] (Fig. 1). All these patients were treated as per WHO
guidelines.
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Fig. 1: Statistical association of platelet count with P. vivax parasite
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The exact mechanism of thrombocytopenia in malaria
is not clear. The commonly reported mechanisms are de-
creased life span of platelets due to immunological and
non-immunological mechanisms, elevated macrophage
colony stimulating factors causing platelet destruction;
ultra structural changes like centralization of dense gran-
ules, glycogen depletion, formation of pseudopods, and
micro aggregation; consumption by diffused intravascu-
lar coagulation (DIC) host oxidative stress through oxi-
dization of membrane lipids causing changes in fluidity
and permeability of the cell membrane and its effect on
fragility2,3. Another mechanism had also been postulated
about removing of platelets from the circulation by con-
sumption in intravascular coagulation, and depletion of
coagulation factors and the presence of fibrinogen degra-
dation products as well as thrombocytopenia parasite den-
sity4–6. Whether the consumption of platelet is the result
of host defence mechanism or vice versa is a matter of
debate7.
Although an inverse relationship between elevated
parasite levels and decreased platelet counts has been re-
ported for P. vivax infection previously8, this observational
study illustrates statistically that platelet count in a pa-
tient of P. vivax monoinfection has no relation with para-
site load in the patient. Whatever the malarial parasite
load is there, platelet count despite the result of either both
immunological and non-immunological mechanisms or host
defense mechanism, not yet clear, definitely doesn’t depend
on parasite load. In other words, it is also true that parasite
load is not true predictor of changes in platelet count.
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